REQUEST A DEMO
Total
USD $0.00
Search more companies

Shanghai Rightongene Biotechnology Co., Ltd. (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Shanghai Rightongene Biotechnology Co., Ltd. Profile Updated: December 22, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Shanghai Rightongene Biotechnology Co., Ltd. focuses on the R&D, production, sales and testing services of in vitro diagnostic products. The company was founded in 2012 and is headquartered in Shanghai City, China.

Headquarters
No. 147, Lane 1817, Huifeng West Road, Fengxian District, Shanghai
Shanghai; Shanghai; Postal Code: 201403

Contact Details: Purchase the Shanghai Rightongene Biotechnology Co., Ltd. report to view the information.

Website: http://www.rightongene.com

Basic Information
Total Employees:
Purchase the Shanghai Rightongene Biotechnology Co., Ltd. report to view the information.
Outstanding Shares:
Purchase the Shanghai Rightongene Biotechnology Co., Ltd. report to view the information.
Registered Capital:
Purchase the Shanghai Rightongene Biotechnology Co., Ltd. report to view the information.
Financial Auditors:
Purchase the Shanghai Rightongene Biotechnology Co., Ltd. report to view the information.
Incorporation Date:
February 17, 2012
Key Executives
Purchase this report to view the information.
Chairman of the Supervisory Board
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
18.22%
Purchase this report to view the information.
11.1%
Purchase this report to view the information.
8.82%
Purchase this report to view the information.
3.58%
Purchase this report to view the information.
2.77%
Subsidiaries
Shanghai Ruiangyuntai Biomedical Technology Co., Ltd.
100%
Shanghai Yuanqi Biomedical Technology Co., Ltd.
100%
Suzhou Yuntai Biomedical Technology Co., Ltd.
100%
Company Performance
Financial values in the chart are available after Shanghai Rightongene Biotechnology Co., Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
-4.62%
Total operating revenue
-4.9%
Operating profit (EBIT)
N/A
Net Profit (Loss) for the Period
-86.02%
Total assets
-5.54%
Total equity
-4.53%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
-4.75%
Return on Equity (ROE)
-0.95%
Debt to Equity Ratio
-0.26%
Quick Ratio
-0.05%
Cash Ratio
0.23%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?